BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang W, Huang F, Feng C. CircFoxo3 Promotes Adriamycin Resistance Through Regulation of miR-199a-5p/ATP Binding Cassette Subfamily C Member 1 Axis in Hepatocellular Carcinoma. Onco Targets Ther 2020;13:5113-22. [PMID: 32606732 DOI: 10.2147/OTT.S243571] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Xue D, Han J, Liang Z, Jia L, Liu Y, Tuo H, Peng Y. Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma. JHC 2022;Volume 9:99-112. [DOI: 10.2147/jhc.s351038] [Reference Citation Analysis]
2 Cai Zhang, Li B, Huang Y, Gao S, Gao X. Biogenesis, Functions, and Cancer Relationships of a Specific Circular RNA: CircFoxo3. Russ J Bioorg Chem 2021;47:1190-200. [DOI: 10.1134/s106816202106025x] [Reference Citation Analysis]
3 Xiong D, He R, Dang Y, Wu H, Feng Z, Chen G. The Latest Overview of circRNA in the Progression, Diagnosis, Prognosis, Treatment, and Drug Resistance of Hepatocellular Carcinoma. Front Oncol 2020;10:608257. [PMID: 33680930 DOI: 10.3389/fonc.2020.608257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lin JC, Zhu NX, Wu LF. Research progress of circRNAs in chemotherapy resistance of digestive system neoplasms. Shijie Huaren Xiaohua Zazhi 2021; 29(21): 1237-1247 [DOI: 10.11569/wcjd.v29.i21.1237] [Reference Citation Analysis]
5 Zhang L, Wang Y, Zhang Y, Zhao Y, Li P. Pathogenic mechanisms and the potential clinical value of circFoxo3 in cancers. Mol Ther Nucleic Acids 2021;23:908-17. [PMID: 33614239 DOI: 10.1016/j.omtn.2021.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang S, Qian L, Cao T, Xu L, Jin Y, Hu H, Fu Q, Li Q, Wang Y, Wang J, Xia Y, Huang X. Advances in the Study of CircRNAs in Tumor Drug Resistance. Front Oncol 2022;12:868363. [DOI: 10.3389/fonc.2022.868363] [Reference Citation Analysis]
7 Rao D, Yu C, Sheng J, Lv E, Huang W. The Emerging Roles of circFOXO3 in Cancer. Front Cell Dev Biol 2021;9:659417. [PMID: 34150756 DOI: 10.3389/fcell.2021.659417] [Reference Citation Analysis]
8 Tao M, Zheng M, Xu Y, Ma S, Zhang W, Ju S. CircRNAs and their regulatory roles in cancers. Mol Med 2021;27:94. [PMID: 34445958 DOI: 10.1186/s10020-021-00359-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bizzarri AR, Cannistraro S. Direct Interaction of miRNA and circRNA with the Oncosuppressor p53: An Intriguing Perspective in Cancer Research. Cancers (Basel) 2021;13:6108. [PMID: 34885216 DOI: 10.3390/cancers13236108] [Reference Citation Analysis]